EPL fixes May 29 record date for ₹50 crore CP maturity

EPL Limited has fixed May 29, 2026, as the record date to determine the eligibility of holders for the maturity proceeds of its Commercial Papers (CPs). The company informed the exchanges that the CPs, aggregating to an amount of ₹50 crore, are due to mature on June 1, 2026.

The securities were issued and allotted on March 2, 2026. This announcement is in accordance with the provisions of Chapter XVII of the SEBI Master Circular and the FAQs for the listing of Commercial Papers issued by the National Stock Exchange of India Limited and BSE Limited.

Details of the Commercial Papers

The company provided specific details regarding the issue, including the ISIN, issue date, maturity date, and the size of the issue.

ISIN	Issue Date	Maturity Date	Record Date	Size of the Issue
INE255A14734	March 2, 2026	June 1, 2026	May 29, 2026	₹50 Crore

The record date is crucial for identifying the shareholders entitled to receive the maturity proceeds on the due date. The company has requested the exchanges to take note of these details for the information and records of the investors.

1 Day	5 Days	1 Month	6 Months	1 Year	5 Years
+0.63%	-5.82%	-6.40%	+8.59%	-7.41%	-12.09%

EPL Limited has released the transcript of its Q4 FY26 earnings conference call held on May 14, 2026. The call, hosted by Systematix Institutional Equities, featured management including Mr. Hemant Bakshi, MD & Global CEO, and Mr. Deepak Goyal, CFO. The transcript is now available on the company's website in compliance with Regulation 30 of SEBI LODR Regulations.

Financial Performance Review

During the call, management highlighted that FY26 was a defining year, with the company delivering its highest revenue growth in five years. Consolidated revenue for Q4 FY26 surged 17.6% year-on-year to Rs. 13,005 million, while full-year revenue grew 13.0% to Rs. 47,631 million. EBITDA for the year increased 15.8% to Rs. 9,724 million, with margins expanding to 20.4%.

Metric	Q4 FY26	Q4 FY25	FY26	FY25
Revenue from Operations (Rs. mn):	13,005	11,054	47,631	42,133
Net Profit After Tax (Rs. mn):	1,033	1,157	3,939	3,638
EBITDA (Rs. mn):	2,632	2,246	9,724	8,396
EBITDA Margin (%):	20.30	20.20	20.40	19.90

Strategic Growth and Merger Update

Mr. Hemant Bakshi stated that the proposed merger with Indovida India Private Limited is a transformational move that will create a nearly $1 billion consumer packaging platform. The combined entity is expected to be margin and value accretive. The management noted that regulatory approvals have been filed, and they hope to complete the merger by Q4 FY27. Until the merger is finalized, both companies cannot declare dividends.

Segment and Regional Performance

Growth was driven by the Beauty & Cosmetics segment, which delivered a record ~30% year-on-year growth, and is now larger than Oral Care in most key markets. Regionally, EAP and the Americas led with 25% and 24.1% growth respectively, while India Standalone grew 11.5%.

Region / Category	Performance
EAP:	25% YoY growth
Americas:	24.10% YoY growth
Europe:	15.50% YoY growth
AMESA:	10.40% YoY growth
India Standalone:	11.50% YoY growth
Beauty & Cosmetics:	~30% YoY growth

Outlook and Guidance

Regarding the Middle East crisis, management confirmed that while raw material costs and availability are challenges, they are confident of recovering the full cost impact through price increases, with over 50% of the business covered under contractual pass-through arrangements. The company reiterated its long-term guidance of low double-digit revenue growth in the range of 11% to 13%.